
Last Price
52 Week Range
$12.91 - $42.13
Next Earnings Date
Feb 19 2026 (Estimate)
Next Earnings Date
Feb 19 2026 (Est.)
Last Price
Company Name | Form Type | Filed | View |
|---|---|---|---|
Travere Therapeutics, Inc. | 8-K | October 30, 2025 | |
Travere Therapeutics, Inc. | 10-Q | October 30, 2025 | |
Travere Therapeutics, Inc. | 8-K | September 10, 2025 | |
Travere Therapeutics, Inc. | 10-Q | August 6, 2025 | |
Travere Therapeutics, Inc. | 8-K | August 6, 2025 | |
Travere Therapeutics, Inc. | 8-K | May 16, 2025 | |
Travere Therapeutics, Inc. | 8-K | May 15, 2025 | |
Travere Therapeutics, Inc. | 10-Q | May 1, 2025 | |
Travere Therapeutics, Inc. | 8-K | May 1, 2025 | |
Travere Therapeutics, Inc. | 8-K | April 30, 2025 | |
Travere Therapeutics, Inc. | ARS | April 1, 2025 | |
Travere Therapeutics, Inc. | DEF 14A | April 1, 2025 | |
Travere Therapeutics, Inc. | DEFA14A | April 1, 2025 | |
Travere Therapeutics, Inc. | 8-K | March 17, 2025 | |
Travere Therapeutics, Inc. | 10-K | February 21, 2025 | |
Travere Therapeutics, Inc. | 8-K | February 20, 2025 | |
Travere Therapeutics, Inc. | 8-K | February 11, 2025 | |
Travere Therapeutics, Inc. | 8-K | January 13, 2025 | |
Travere Therapeutics, Inc. | 8-K | November 8, 2024 | |
Travere Therapeutics, Inc. | 8-K | October 31, 2024 | |
Travere Therapeutics, Inc. | 10-Q | October 31, 2024 | |
Travere Therapeutics, Inc. | 8-K | September 26, 2024 | |
Travere Therapeutics, Inc. | 8-K | September 6, 2024 | |
Travere Therapeutics, Inc. | S3ASR | August 1, 2024 | |
Travere Therapeutics, Inc. | 8-K | August 1, 2024 | |
Travere Therapeutics, Inc. | 10-Q | August 1, 2024 | |
Travere Therapeutics, Inc. | 8-K | May 13, 2024 | |
Travere Therapeutics, Inc. | 8-K | May 6, 2024 | |
Travere Therapeutics, Inc. | 10-Q | May 6, 2024 | |
Travere Therapeutics, Inc. | 8-K | April 24, 2024 |
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.